Down-regulation of matrix metalloproteinase-9 by pyrrolidine dithiocarbamate prevented retinal ganglion cell death after transection of optic nerve in rats

Current Eye Research

Volumn 36, Issue 11, 2011, Pages 1053-1063

  Sun, Ming Hui ^a   Chen, Kuan Jen ^a   Tsao, Yeou Ping ^b   Kao, Ling Yuh ^a   Han, Wen Hwa ^b   Lin, Ken Kuo ^a   Pang, Jong Hwei Su ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b MACKAY MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Matrix metalloproteinases 9; Nuclear factor light chain enhancer of activated B cells; Optic nerve transection; Pyrrolidine dithiocarbamate; Retinal ganglion cells

Indexed keywords

GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PYRROLIDINE DITHIOCARBAMATE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; ENZYME INHIBITION; IMMUNOHISTOCHEMISTRY; MALE; NERVE TRANSECTION; NEUROPROTECTION; NONHUMAN; OPTIC NERVE; OPTIC NERVE SECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA GANGLION CELL; UPREGULATION; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; BLOTTING, WESTERN; CELL COUNT; DISEASE MODELS, ANIMAL; DOWN-REGULATION; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MALE; MATRIX METALLOPROTEINASE 9; OPTIC NERVE; PROLINE; RATS; RATS, SPRAGUE-DAWLEY; RETINAL DISEASES; RETINAL GANGLION CELLS; THIOCARBAMATES;

EID: 80054688275     PISSN: 02713683     EISSN: 14602202     Source Type: Journal    
DOI: 10.3109/02713683.2011.606591     Document Type: Article

References (52)

1. Berkelaar M, Clarke DB, Wang YC, Bray GM, Aguayo AJ. Axotomy results in delayed death and apoptosis of retinal ganglion cells in adult rats. J Neurosci 1994;14:4368-4374. (Pubitemid 24200558)
2. Garcia-Valenzuela E, Gorczyca W, Darzynkiewicz Z, Sharma SC. Apoptosis in adult retinal ganglion cells after axotomy. J Neurobiol 1994;25:431-438. (Pubitemid 24093925)
3. Barde YA. Trophic factors and neuronal survival. Neuron 1989;2:1525-1534.
4. Kermer P, Ankerhold R, Klöcker N, Krajewski S, Reed JC, Bähr M. Caspase-9: involvement in secondary death of axo-tomized rat retinal ganglion cells in vivo. Brain Res Mol Brain Res 2000;85:144-150. (Pubitemid 32056245)
5. Kermer P, Klöcker N, Labes M, Thomsen S, Srinivasan A, Bähr M. Activation of caspase-3 in axotomized rat retinal ganglion cells in vivo. FEBS Lett 1999;453:361-364. (Pubitemid 29326679)
6. Isenmann S, Wahl C, Krajewski S, Reed JC, Bähr M. Up-regulation of Bax protein in degenerating retinal ganglion cells precedes apoptotic cell death after optic nerve lesion in the rat. Eur J Neurosci 1997;9:1763-1772. (Pubitemid 27348335)
7. McKernan DP, Cotter TG. A Critical role for Bim in retinal ganglion cell death. J Neurochem 2007;102:922-930. (Pubitemid 47057287)
8. Peng PH, Chiou LF, Chao HM et al. Effects of epigallocate-chin-3-gallate on rat retinal ganglion cells after optic nerve axotomy. Exp Eye Res 2010;90:528-534.
9. Luo JM, Cen LP, Zhang XM et al. PI3K/akt, JAK/STAT and MEK/ERK pathway inhibition protects retinal ganglion cells via different mechanisms after optic nerve injury. Eur J Neurosci 2007;26:828-842.
10. Koeberle PD, Ball AK. Nitric oxide synthase inhibition delays axonal degeneration and promotes the survival of axoto-mized retinal ganglion cells. Exp Neurol 1999;158:366-381. (Pubitemid 29382827)
11. Yoles E, Muller S, Schwartz M. NMDA-receptor antagonist protects neurons from secondary degeneration after partial optic nerve crush. J Neurotrauma 1997;14:665-675. (Pubitemid 27424269)
12. Werb Z. ECM and cell surface proteolysis: regulating cellular ecology. Cell 1997;91:439-442. (Pubitemid 27508232)
13. Birkedal-Hansen H, Moore WG, Bodden MK et al. Matrix metal-loproteinases: a review. Crit Rev Oral Biol Med 1993;4:197-250.
14. Sivak JM, Fini ME. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res 2002;21:1-14. (Pubitemid 34242704)
15. Rosenberg GA, Estrada EY, Dencoff JE. Matrix metallo-proteinases and TIMPs are associated with blood-brain barrier opening after reperfusion in rat brain. Stroke 1998;29:2189-2195. (Pubitemid 28443538)
16. Siebert H, Dippel N, Mäder M, Weber F, Brück W. Matrix metalloproteinase expression and inhibition after sciatic nerve axotomy. J Neuropathol Exp Neurol 2001;60:85-93. (Pubitemid 32097008)
17. Rivera S, Ogier C, Jourquin J et al. Gelatinase B and TIMP-1 are regulated in a cell-and time-dependent manner in association with neuronal death and glial reactivity after global forebrain ischemia. Eur J Neurosci 2002;15:19-32. (Pubitemid 35478006)
18. Fini ME, Parks WC, Rinehart WB et al. Role of matrix metal-loproteinases in failure to re-epithelialize after corneal injury. Am J Pathol 1996;149:1287-1302. (Pubitemid 26337246)
19. Plantner JJ, Jiang C, Smine A. Increase in interphotorecep-tor matrix gelatinase A (MMP-2) associated with age-related macular degeneration. Exp Eye Res 1998;67:637-645. (Pubitemid 29052401)
20. Das A, McGuire PG, Eriqat C et al. Human diabetic neo-vascular membranes contain high levels of urokinase and metalloproteinase enzymes. Invest Ophthalmol Vis Sci 1999;40:809-813. (Pubitemid 29109465)
21. Agapova OA, Ricard CS, Salvador-Silva M, Hernandez MR. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes. Glia 2001;33:205-216. (Pubitemid 32219129)
22. Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990;6:121-125.
23. Zhang X, Sakamoto T, Hata Y et al. Expression of matrix metalloproteinases and their inhibitors in experimental retinal ischemia-reperfusion injury in rats. Exp Eye Res 2002;74:577-584. (Pubitemid 34757013)
24. Zhang X, Chintala SK. Influence of interleukin-1 β induction and mitogen-activated protein kinase phos-phorylation on optic nerve ligation-induced matrix metal-loproteinase-9 activation in the retina. Exp Eye Res 2004;78: 849-860. (Pubitemid 38252961)
25. Zhang X, Cheng M, Chintala SK. Optic nerve ligation leads to astrocyte-associated matrix metalloproteinase-9 induction in the mouse retina. Neurosci Lett 2004;356:140-144. (Pubitemid 38121488)
26. Chintala SK, Zhang X, Austin JS, Fini ME. Defciency in matrix metalloproteinase gelatinase B (MMP-9) protects against retinal ganglion cell death after optic nerve ligation. J Biol Chem 2002;277:47461-47468. (Pubitemid 36159263)
27. Guo L, Moss SE, Alexander RA, Ali RR, Fitzke FW, Cordeiro MF. Retinal ganglion cell apoptosis in glaucoma is related to intraocular pressure and IOP-induced effects on extracellular matrix. Invest Ophthalmol Vis Sci 2005;46:175-182. (Pubitemid 40041195)
28. Mercurio F, Manning AM. Multiple signals converging on NF-κB. Curr Opin Cell Biol 1999;11:226-232.
29. Grilli M, Memo M. Possible role of NF-κB and p53 in the glutamate-induced pro-apoptotic neuronal pathway. Cell Death Differ 1999;6:22-27. (Pubitemid 29051851)
30. Choi JS, Sungjoo KY, Joo CK. NF-κ B activation following optic nerve transection. Korean J Ophthalmol 1998;12:19-24.
31. Manabe S, Gu Z, Lipton SA. Activation of matrix metallopro-teinase-9 via neuronal nitric oxide synthase contributes to NMDA-induced retinal ganglion cell death. Invest Ophthalmol Vis Sci 2005;46:4747-4753. (Pubitemid 44264580)
32. Gasche Y, Soccal PM, Kanemitsu M, Copin JC. Matrix met-alloproteinases and diseases of the central nervous system with a special emphasis on ischemic brain. Front Biosci 2006;11:1289-1301. (Pubitemid 43253422)
33. Azeh I, Mäder M, Smirnov A, Beuche W, Nau R, Weber F. Experimental pneumococcal meningitis in rabbits: the increase of matrix metalloproteinase-9 in cerebrospi-nal fuid correlates with leucocyte invasion. Neurosci Lett 1998;256:127-130. (Pubitemid 28546906)
34. Kieseier BC, Clements JM, Pischel HB et al. Matrix metallo-proteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barré syndrome. Ann Neurol 1998;43:427-434. (Pubitemid 28231716)
35. Kieseier BC, Seifert T, Giovannoni G, Hartung HP. Matrix metalloproteinases in infammatory demyelination: targets for treatment. Neurology 1999;53:20-25. (Pubitemid 29329643)
36. Stüve O, Dooley NP, Uhm JH et al. Interferon β-1b decreases the migration of T lymphocytes in vitro: effects on matrix metalloproteinase-9. Ann Neurol 1996;40:853-863. (Pubitemid 27044603)
37. Agapova OA, Kaufman PL, Lucarelli MJ, Gabelt BT, Hernandez MR. Differential expression of matrix metallo-proteinases in monkey eyes with experimental glaucoma or optic nerve transection. Brain Res 2003;967:132-143. (Pubitemid 36324295)
38. Asahi M, Wang X, Mori T et al. Effects of matrix metallopro-teinase-9 gene knock-out on the proteolysis of blood-brain barrier and white matter components after cerebral ischemia. J Neurosci 2001;21:7724-7732. (Pubitemid 32904971)
39. Noble LJ, Donovan F, Igarashi T, Goussev S, Werb Z. Matrix metalloproteinases limit functional recovery after spinal cord injury by modulation of early vascular events. J Neurosci 2002;22:7526-7535. (Pubitemid 35386354)
40. Ahmed Z, Dent RG, Leadbeater WE, Smith C, Berry M, Logan A. Matrix metalloproteases: degradation of the inhibitory environment of the transected optic nerve and the scar by regenerating axons. Mol Cell Neurosci 2005;28:64-78. (Pubitemid 39656012)
41. Yu YM, Lin HC. Curcumin prevents human aortic smooth muscle cells migration by inhibiting of MMP-9 expression. Nutr Metab Cardiovasc Dis 2010;20:125-132.
42. Rhee JW, Lee KW, Sohn WJ et al. Regulation of matrix met-alloproteinase-9 gene expression and cell migration by NF-κ B in response to CpG-oligodeoxynucleotides in RAW 264.7 cells. Mol Immunol 2007;44:1393-1400. (Pubitemid 44415954)
43. Grossmann J. Molecular mechanisms of "detachment-induced apoptosis-Anoikis". Apoptosis 2002;7:247-260.
44. Choi JS, Kim JA, Kim DH et al. Failure to activate NF-κB promotes apoptosis of retinal ganglion cells following optic nerve transection. Brain Res 2000;883:60-68.
45. Kitaoka Y, Kumai T, Kitaoka Y et al. Nuclear factor-κ B p65 in NMDA-induced retinal neurotoxicity. Brain Res Mol Brain Res 2004;131:8-16. (Pubitemid 39458272)
46. Wang J, Jiang S, Kwong JM, Sanchez RN, Sadun AA, Lam TT. Nuclear factor-κB p65 and upregulation of interleukin-6 in retinal ischemia/reperfusion injury in rats. Brain Res 2006;1081:211-218.
47. Parodi FE, Mao D, Ennis TL, Bartoli MA, Thompson RW. Suppression of experimental abdominal aortic aneurysms in mice by treatment with pyrrolidine dithiocarbamate, an antioxidant inhibitor of nuclear factor-κB. J Vasc Surg 2005;41:479-489. (Pubitemid 40523593)
48. Nurmi A, Goldsteins G, Närväinen J et al. Antioxidant pyr-rolidine dithiocarbamate activates Akt-GSK signaling and is neuroprotective in neonatal hypoxia-ischemia. Free Radic Biol Med 2006;40:1776-1784.
49. Ziegler-Heitbrock HW, Sternsdorf T, Liese J et al. Pyrrolidine dithiocarbamate inhibits NF-κ B mobilization and TNF production in human monocytes. J Immunol 1993;151:6986-6993. (Pubitemid 24001073)
50. Lewis GP, Erickson PA, Guérin CJ, Anderson DH, Fisher SK. Basic fbroblast growth factor: a potential regulator of proliferation and intermediate flament expression in the retina. J Neurosci 1992;12:3968-3978.
51. Brand K, Page S, Rogler G et al. Activated transcription factor nuclear factor-κ B is present in the atherosclerotic lesion. J Clin Invest 1996;97:1715-1722. (Pubitemid 26105480)
52. Goetzl EJ, Banda MJ, Leppert D. Matrix metalloproteinases in immunity. J Immunol 1996;156:1-4. (Pubitemid 26006939)